Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Trends in the use of routine therapies in cystic fibrosis: 1995-2005.
Konstan MW, VanDevanter DR, Rasouliyan L, Pasta DJ, Yegin A, Morgan WJ, Wagener JS; Scientific Advisory Group; Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Konstan MW, et al. Among authors: wagener js. Pediatr Pulmonol. 2010 Dec;45(12):1167-72. doi: 10.1002/ppul.21315. Epub 2010 Aug 17. Pediatr Pulmonol. 2010. PMID: 20717935 Free PMC article.
Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution.
Konstan MW, Davis PB, Wagener JS, Hilliard KA, Stern RC, Milgram LJ, Kowalczyk TH, Hyatt SL, Fink TL, Gedeon CR, Oette SM, Payne JM, Muhammad O, Ziady AG, Moen RC, Cooper MJ. Konstan MW, et al. Among authors: wagener js. Hum Gene Ther. 2004 Dec;15(12):1255-69. doi: 10.1089/hum.2004.15.1255. Hum Gene Ther. 2004. PMID: 15684701 Clinical Trial.
Impact of pregnancy on women with cystic fibrosis.
McMullen AH, Pasta DJ, Frederick PD, Konstan MW, Morgan WJ, Schechter MS, Wagener JS. McMullen AH, et al. Among authors: wagener js. Chest. 2006 Mar;129(3):706-11. doi: 10.1378/chest.129.3.706. Chest. 2006. PMID: 16537871
Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis.
Konstan MW, Morgan WJ, Butler SM, Pasta DJ, Craib ML, Silva SJ, Stokes DC, Wohl ME, Wagener JS, Regelmann WE, Johnson CA; Scientific Advisory Group and the Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Konstan MW, et al. Among authors: wagener js. J Pediatr. 2007 Aug;151(2):134-9, 139.e1. doi: 10.1016/j.jpeds.2007.03.006. Epub 2007 Jun 22. J Pediatr. 2007. PMID: 17643762
Shifting patterns of inhaled antibiotic use in cystic fibrosis.
Moskowitz SM, Silva SJ, Mayer-Hamblett N, Pasta DJ, Mink DR, Mabie JA, Konstan MW, Wagener JS; Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis (ESCF). Moskowitz SM, et al. Among authors: wagener js. Pediatr Pulmonol. 2008 Sep;43(9):874-81. doi: 10.1002/ppul.20873. Pediatr Pulmonol. 2008. PMID: 18668689
Relationship between inhaled corticosteroid therapy and rate of lung function decline in children with cystic fibrosis.
Ren CL, Pasta DJ, Rasouliyan L, Wagener JS, Konstan MW, Morgan WJ; Scientific Advisory Group and the Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Ren CL, et al. Among authors: wagener js. J Pediatr. 2008 Dec;153(6):746-51. doi: 10.1016/j.jpeds.2008.07.010. Epub 2008 Aug 30. J Pediatr. 2008. PMID: 18760805
103 results